As the global economy navigates a post-pandemic world, investors are keenly observing evolving market dynamics, including shifts in consumer behavior and technological advancements.
On CNBC’s “Halftime Report Final Trades,” Sarat Sethi, managing partner at DCLA, said he is sticking with Johnson & Johnson (NYSE:JNJ) amid a positive earnings report.
On Wednesday, Johnson & Johnson raised its FY2025 earnings guidance. The company reported a second-quarter 2025 adjusted earnings of $2.77 …
Full story available on Benzinga.com
As the global economy navigates a post-pandemic world, investors are keenly observing evolving market dynamics, including shifts in consumer behavior and technological advancements.
On CNBC’s “Halftime Report Final Trades,” Sarat Sethi, managing partner at DCLA, said he is sticking with Johnson & Johnson (NYSE:JNJ) amid a positive earnings report.
On Wednesday, Johnson & Johnson raised its FY2025 earnings guidance. The company reported a second-quarter 2025 adjusted earnings of $2.77 …
Full story available on Benzinga.com
As the global economy navigates a post-pandemic world, investors are keenly observing evolving market dynamics, including shifts in consumer behavior and technological advancements.
On CNBC’s “Halftime Report Final Trades,” Sarat Sethi, managing partner at DCLA, said he is sticking with Johnson & Johnson (NYSE:JNJ) amid a positive earnings report.
On Wednesday, Johnson & Johnson raised its FY2025 earnings guidance. The company reported a second-quarter 2025 adjusted earnings of $2.77 …Full story available on Benzinga.com Read MoreEMR, IBIT, ICE, JNJ, Long Ideas, News, Markets, Media, Trading Ideas, EMR, US2910111044, ICE, US45865V1008, JNJ, US4781601046, IBIT, Long Ideas, News, Markets, Media, Trading Ideas, Benzinga Markets
